Reddit Posts
CHRS: 14% short interest on a highly promising small cap
CHRS: a highly promising biotech poised to break out
CHRS: a promising biotech poised to break out
CHRS: Notes from today's JP Morgan Health Care Conference presentation
CHRS to the moon baby! My tits are jacked!
$CHRS received FDA approval yesterday: ) Currently on sale, buying the dip!
Coherus will be up big today due to FDA approval—$CHRS
CHRS: A heavily shorted biotech with major catalysts upcoming
CHRS: A heavily shorted biotech with major catalysts upcoming
#premarket 08/19 $SONN - S1 sec reports, $SLRX - no news, $ESGC - The Huge Amazon Deal Leaving Eros STX Global Starstruck. $CHRS - Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01.. Any trading ideas? Welcome!
Coherus Bioscienes ($CHRS) is finally killing it, here’s why you should care.
A casualty GEM among the Biotech selloff
A Hidden GEM that has been a casualty of the recent Biotech Breakdown
Mentions
Exactly! Maximum pessimism + high short interest + catalyst = squeeze city. The dilution point is real, though. BUT with $250M cash and 2+ year runway, they'd have to be complete morons to dilute at $0.86. That's the beauty - the cash position basically removes dilution risk in the near term. ATYR ripping today is exactly the kind of action we could see. Biotech shorts are skittish AF right now. Once one starts running, they all get nervous. CHRS is basically a loaded spring. Might sit here for weeks doing nothing, then one random PR and boom - shorts scrambling for the exits. The "can't get any lower" thesis is my favourite setup. Worst case we're wrong and it stays at the same level
Okay got it now! It’s a squeeze-gamble. I really like the „can’t get any lower, must get up“-part. Unless that happens in the form of dilution ☠️ ATYR shorts got to squeezing today, maybe CHRS will do to!
CHRS should pop off around July 31st Q2 earnings - that's when we see the real numbers post-divestiture. As for ATOS? No fucking clue lol. Every prediction I've made on that one has been dead wrong. Only thing I know is their CEO Steven Quay has more wrinkles than a raisin - dude's smart as hell 🧠 But I've learned to never try timing biotech. Could moon tomorrow or crab for months 🦀
For pennystock winnings I usually spread them out. I take some and put them in longer holds and then the rest I keep in the pennystock fund. With these winnings I added to my ATYR, and RKLB position, then some in CHRS. The rest I’m keeping idle as there isn’t anything short term that I’ve looked at that I need to gamble on.
Nice find.. I traded half my ATOS shares and bought the same amount of CHRS (they traded at the exact same price). Let's see which Biotech wins the race or both will crash and burn.
They're on NASDAQ CHRS. Check if your broker allows penny stock trading - some require special permissions.
Forgot to mention CHRS with a MC below cash
Does CHRS have squeeze potential? 🤔
For certain $CHRS. Been watching this week. Average price target of $5.50\~ and it's only at $1.13 right now,.
They sold another product for $550 MM in Q4 2024 to clear $250MM debt. Now they should have more cash to run the clinical studies and on of the Phase II clinical studies showed promising results. CHRS is seriously under valued IMO.
Thanks a lot for the write up, some very interesting points. I just made my first trade in a penny stock after a few significant wins. Read about $CHRS, who on paper seem to be a very attractive turn around candidate.. but as you said, timing is everything, so I pretty much am catching the knife right now. I am down 30% within a few days and I am just struggling with the thought of just accepting bad timing vs. holding out for possibly quite some time.
CHRS has strong fundamentals that the market is overlooking. Their UDENYCA drug [generated $93.58M in revenue in H1 2024, up 60% YoY](https://beyondspx.com/article/coherus-biosciences-inc-nasdaq-chrs-a-promising-oncology-and-biosimilar-player-navigating-a-dynamic-market). They also just launched LOQTORZI for cancer treatment which adds another revenue stream. The recent divestitures of CIMERLI and YUSIMRY brought in over $227M cash, strengthening their balance sheet. Net losses are shrinking too - Q2 2024 loss was only $13M vs $43M last year. But the debt load is heavy with a 1.40 debt/cap ratio. They'll need UDENYCA and LOQTORZI sales to keep ramping up to service that debt. The current price doesn't reflect the improving fundamentals. This looks like a solid entry point for a turnaround play. Just be ready for volatility since they're still not profitable yet.
My 3 moon shots. KULR, ONDS, CHRS.
CHRS anyone? Small cap bio that could have huge upside.
Buy CHRS, a really promising biotech
Buy CHRS and hold for three years
I just started investing but currently im really proud of CHRS, got in at around 0.77 and now its around 1.2. I am really ashamed of APLM.
I would take CHRS over this.
Anyone have a beat on Coherus Biosciences (CHRS)? they looked like they managed to exceed expectations for Q2 but the stock is still dirt cheap (currently at $0.75)
I like CHRS too, made alot of money swing trading it. But do you happen to know when the labeling fiasco is resolved and when they will be shipping product again? Thanks
You were right about IBRX so I'm behind you 100% 🚀🌕 Except for CHRS lol 😆
oh man... $CHRS bag holder here. So sad.. last week on twits someone said "Post your breakeven" and many were up near $2 😥 ~ So been following closely. There are reasons analysts are sticking to $8 even $12 PT ? They do have drugs in the pipeline.
OK, thanks. No, not an adjusted contract. Just a normal put option. The stock is CHRS (Coherus BioSciences, Inc.).
Hmm, I spent far too long formatting the stock table, looks like it did not work. Okay, I have in this account: DDOG (400) TSLA (214) TTD (300) SNOW (132) NVDA (24) MNDY (100) CHRS (7,200) ZS (84) MELI (5)
CHRS (earnings today after close)
Buying $CHRS before tomorrow's close. They had a drug approval by the FDA on october (which applies to tomorrow's earnings) and had positive data on a clinical trial last January.
I'm loving CHRS, right now. I have about 500 shares, rn. I plan to get more in the morning. This is a solid legit company at a discount price. Get in low while you can!!
CHRS is doing good right now!
Any shareholders with significant ownership of CHRS out there? Would love to hear your thoughts on the company / products / management (especially negative ones!).
So you just moved from GEVO to CHRS pumping. How heavy is your bag?
I’m gonna try $CHRS, cancer therapy with earnings in 3 weeks, maybe putins cancer vaccine claim gets us to speed up our stuff
**CHRS is primed to rocket.**
CHRS is looking juicy. Short interest over 25%. 90% tute held. Under short attack but with all positive corporate progress. Solid cash projection: [https://www.reddit.com/r/CHRS/comments/1agps2e/june\_2024\_cash\_projections/](https://www.reddit.com/r/CHRS/comments/1agps2e/june_2024_cash_projections/)
Opinion on CHRS and their biosimilar?
ADCT and CHRS. You're welcome.
ADCT and CHRS. You're welcome.
Everybody loves CHRS (bioscience firm got fda approval 1 hour ago up 20% after market, could fly in the morning)
Are you still holding? CHRS is a dog's breakfast at the moment.
💰💰 Coherus (CHRS) has been knocked in **HALF** in just three days on a massive short attack. My money is on a beautiful squeeze (20%+ SI). 💰💰
Buying coherus bioscience inc CHRS it’s got next stage go ahead for oncology break through and is going to boom
I had the same thing I took my 2k loss and moved it to CHRS got almost half of it back. I believe these Chinese companies are hit or miss. I have had good lucks with them but only short term never stayed with any of them for more than a month.
5 months ago this account was posting that CHRS was “poised like a rocket ship”, it then lost like 2/3rds of its value. Then a little over a week ago it rallied back. Take a guess what it’s about to do. This is just some shill account trying to find some fool to hold the bag on this pump and dump.
Hasn't been profitable yet, it's lost 36.56% value since first price in 2014. It would be a better idea to just buy SNP500 or put money into a mattress over CHRS
Can't tell if this is an ad for CHRS or not.
>There are very few companies that will have as many high-value products on the market as CHRS will this summer. Their strong product portfolio, combined with their favorable financial position, gives them a distinct competitive advantage.
Buy CHRS and enjoy an amazing ride this year
Buy CHRS, an exciting biotech
Buy CHRS and hold for two years
CHRS is less than two months from major drug approval
I’m going to give you the best advice you’re going to get. Buy CHRS and check back in two years
Buy CHRS ahead of important drug approval Dec. 23
CHRS ahead of Dec. 23 major drug approval
CHRS amid lucentis biosimilar launch and ahead of key drug approval in December
Buy CHRS and check back in two years
Take 10%, buy CHRS and check back in two years
Buy CHRS and check back in two years
I believe CHRS will be a $100 stock in two years
I’ve yolo’ed my account on CHRS, a highly promising biotech with four product launches in the next ten months
CHRS, a promising small cap biotech with four products launching in the next 10 months
Buy CHRS and check back in two years
Buy CHRS and check back in two years
Just keep accumulating CHRS ahead of four product launches in the next 11 months
Anyone playing any retarded pharma plays? $CHRS is a good pick
CHRS,small cap biotech currently losing money but will move up sharply with four products launching in the next 11 months